insights_auto
Why is BMY up ၄.၂၂%?
Dive Deeperchevron_right
BMY:NYSE
Bristol-Myers Squibb Co
၅၉.၀၆ US$
arrow_upward
+၄.၂၂%(+၂.၃၉) 1D
အောက် ၁၄, GMT-၄ ၁၄:၃၆:၅၆ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BMY...
Open
၅၆.၈၁ US$
High
၅၉.၁၂ US$
Low
၅၆.၅၈ US$
Mkt. cap
ဋေ ၁.၂၁ သ
Avg. vol.
၁.၂၁ ကုဋေ
Volume
၅.၉၉ သန်း
Dividend
၄.၂၇%
Quarterly dividend
၀.၆၃ US$
Ex-dividend date
၂၀၂၆ အောက် ၂
P/E ratio
၁၃.၀၁
52-wk high
၆၈.၆၄ US$
52-wk low
၄၂.၅၂ US$
EPS
၄.၅၄ US$
Beta
၀.၁၉
Shares outstanding
၂၀၄.၂၇ ဋေ
No. of employees
၃ သောင်း
Open
၅၆.၈၁ US$
High
၅၉.၁၂ US$
Low
၅၆.၅၈ US$
Mkt. cap
ဋေ ၁.၂၁ သ
Avg. vol.
၁.၂၁ ကုဋေ
Volume
၅.၉၉ သန်း
Dividend
၄.၂၇%
Quarterly dividend
၀.၆၃ US$
Ex-dividend date
၂၀၂၆ အောက် ၂
P/E ratio
၁၃.၀၁
52-wk high
၆၈.၆၄ US$
52-wk low
၄၂.၅၂ US$
EPS
၄.၅၄ US$
Beta
၀.၁၉
Shares outstanding
၂၀၄.၂၇ ဋေ
No. of employees
၃ သောင်း
News stories
From web sources and news partners
Zacks
·
ပြီးခဲ့သည့် ၃ နာရီ
Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?
Simply Wall Street
·
ပြီးခဲ့သည့် ၄ နာရီ
Why Bristol-Myers Squibb (BMY) Is Back In The Spotlight
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၅ နာရီ
Wells Fargo cuts target for Bristol Myers Squibb stock to USD 60.00
Zacks
·
ပြီးခဲ့သည့် ၅ နာရီ
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Co
CEOChris Boerner
Employees၃.၂၅ သောင်း
Founded၁၈၈၇
Headquartersနယူးယောက်မြို့, နယူးယောက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitebms.com